```html

Jerusalem Hares' Fever (Mediated by Rickettsia) – A Comprehensive Medical Guide

Overview

Jerusalem hares’ fever (sometimes called “Jerusalem hare spotted fever” or “Mediterranean typhus”) is a zoonotic infection caused by intracellular bacteria of the genus Rickettsia, most commonly Rickettsia conorii sub‑species israelensis. The disease is transmitted to humans through the bite of infected ticks that parasitize the wild hare (*Lepus capensis*), a species native to the Middle East and parts of North Africa. The infection presents with a febrile illness, characteristic rash, and, in severe cases, multi‑organ involvement.

• Geographic distribution: Primarily reported in Israel, the West Bank, Jordan, and parts of Southern Turkey. Sporadic cases have been documented in travelers returning from these regions.
• Population affected: Most cases occur in adults aged 20‑60 who work outdoors (farmers, wildlife researchers, hikers) or live in rural communities where hares and tick vectors are common.
• Prevalence: Exact incidence is unclear because the disease is under‑reported. The Israeli Ministry of Health recorded 112 confirmed cases between 2015‑2022, a rate of roughly 1.5 cases per 100,000 inhabitants in endemic districts.<sup>1</sup>

Symptoms

The clinical picture evolves in three phases: incubation (2‑10 days), acute febrile phase (3‑7 days), and convalescent phase (1‑3 weeks). Not every patient experiences all symptoms.

Common early symptoms

• Fever: Sudden onset of high fever (38.5‑40 °C/101‑104 °F).
• Headache: Often described as “band‑like” and may be severe.
• Myalgia & arthralgia: Muscle aches, especially in the calves and lower back.
• Fatigue: Generalized weakness that can last weeks.
• Gastro‑intestinal upset: Nausea, loss of appetite, occasional vomiting.

Skin manifestations

• Eschar (tache noire): A dark, necrotic papule at the site of the tick bite, typically 5‑10 mm in diameter, surrounded by an erythematous halo. Seen in 40‑60 % of patients.<sup>2</sup>
• Maculopapular rash: Begins on the trunk 2‑4 days after fever onset, then spreads centrifugally to the limbs and sometimes the palms/soles.
• Petechial or vesicular lesions: Less common but may indicate more severe disease.

Severe or systemic signs (appear in 10‑20 % of cases)

• Confusion or altered mental status.
• Hypotension or shock.
• Acute kidney injury (rise in serum creatinine).
• Hepatitis (elevated transaminases).
• Pulmonary involvement – cough, dyspnea, infiltrates.
• Cardiac involvement – myocarditis, pericardial effusion.

Causes and Risk Factors

Etiology

The disease is caused by Rickettsia conorii sub‑species israelensis, an obligate intracellular gram‑negative bacterium. It infects endothelial cells, leading to vasculitis that underlies the rash and organ damage.

Transmission cycle

1. Wild hares harbor the bacteria in their blood.
2. Ticks (primarily Rhipicephalus sanguineus and Rhipicephalus turanicus) feed on infected hares and become carriers.
3. Humans acquire infection when an infected tick attaches and feeds for ≥6 hours.

Risk factors

• Living or working in endemic rural areas.
• Occupations with frequent wildlife exposure (agriculture, game‑keeping, veterinary work).
• Outdoor recreation during tick‑active months (April‑October).
• Failure to use personal protective measures (long sleeves, tick repellents).
• Pre‑existing immunosuppression (e.g., HIV, chemotherapy) – increases risk of severe disease.

Diagnosis

Because early symptoms mimic many viral or bacterial infections, a high index of suspicion is essential, especially in travelers from endemic regions.

Clinical criteria

• Acute fever + one or more of the following: eschar, characteristic rash, recent tick exposure in an endemic area.

Laboratory tests

• Complete blood count (CBC): May show mild leukocytosis or leukopenia; thrombocytopenia is common.
• Liver function tests: Elevated AST/ALT in 30‑40 % of patients.
• Renal panel: Creatinine rise indicates renal involvement.
• Serology (Indirect Immunofluorescence Assay – IFA): Detects IgG/IgM antibodies; a ≥four‑fold rise between acute and convalescent samples confirms infection. Sensitivity >85 % after day 7.
• Polymerase Chain Reaction (PCR): Detects Rickettsia DNA from blood, skin biopsy of the eschar, or tick specimens. PCR is the fastest definitive test (results in 24‑48 h).
• Skin biopsy: Histology reveals vasculitis; PCR on biopsy material can aid diagnosis.

Differential diagnosis

Consider other rickettsial diseases (Mediterranean spotted fever, scrub typhus), viral exanthems, meningococcemia, and early Lyme disease.

Treatment Options

Prompt antimicrobial therapy markedly reduces morbidity and mortality. The gold‑standard treatment is doxycycline.

First‑line antimicrobial therapy

• Doxycycline: 100 mg orally or IV every 12 hours for 7‑10 days. In pregnant women or children <8 years, chloramphenicol 50 mg/kg/day divided q6h is an alternative, though less effective.
• Evidence shows <90‑95 % cure rate when started within the first 5 days of illness.<sup>3</sup>

Adjunctive care

• Hydration and electrolyte management.
• Antipyretics (acetaminophen) for fever; avoid NSAIDs if renal dysfunction is present.
• Supportive organ‑specific care (e.g., diuretics for pulmonary edema, renal dialysis if severe AKI).

When doxycycline is contraindicated

• Pregnancy: Azithromycin 500 mg PO daily for 5 days has shown modest efficacy in limited studies.<sup>4</sup>
• Severe allergy to tetracyclines: Chloramphenicol or fluoroquinolones (e.g., ciprofloxacin 500 mg BID) may be considered, though resistance data are scarce.

Duration of therapy

Continue treatment until the patient is afebrile for ≥48 hours and the rash has resolved, typically no shorter than 7 days.

Living with Jerusalem Hares' Fever (Mediated by Rickettsia)

After successful treatment

• Schedule a follow‑up visit 2‑3 weeks after completing antibiotics to confirm symptom resolution and normal laboratory values.
• Most people recover completely; however, mild fatigue can persist for several weeks.

Managing lingering symptoms

• Fatigue: Gradual return to normal activity, balanced with rest; consider a short, supervised exercise program.
• Joint pain: Over‑the‑counter analgesics (acetaminophen) and gentle stretching.
• Skin changes: Hyperpigmentation may linger at the site of the eschar. Use sunscreen and moisturizers; it usually fades within 3–6 months.

Psychological impact

Acute febrile illness can be frightening. If anxiety or persistent worry about recurrence occurs, discuss with your primary care provider; counseling or support groups for tick‑borne diseases can be helpful.

Prevention

• Personal protective measures
  • Wear long sleeves, long trousers, and light‑colored clothing to spot ticks.
  • Apply EPA‑registered tick repellents containing 20‑30 % DEET, picaridin, or IR3535 on exposed skin.
  • Treat clothing and gear with 0.5 % permethrin.
• Environmental control
  • Keep grass trimmed and remove leaf litter around homes and animal pens.
  • Use acaricides on domestic animals and in areas known for high tick density.
• Tick checks
  • Conduct a thorough body examination within 24 hours after outdoor activities.
  • Remove attached ticks promptly with fine‑tipped tweezers, grasping as close to the skin as possible and pulling straight out.
• Education for high‑risk groups
  • Farmers, wildlife researchers, and hikers should receive training on tick identification and safe removal.
  • Travel clinics should advise visitors to endemic regions about preventive measures.

Complications

While the majority of cases resolve without permanent damage, delayed treatment or severe disease can lead to serious complications:

• Vasculitis‑related organ damage: Cerebral infarcts, encephalitis, or peripheral neuropathy.
• Acute renal failure: May require temporary dialysis; mortality rises to 15‑20 % in those with renal involvement.
• Hepatic failure: Jaundice and coagulopathy.
• Respiratory distress: Acute respiratory distress syndrome (ARDS) in <5 % of severe cases.
• Cardiac complications: Myocarditis, arrhythmias, or heart block.
• Secondary bacterial infections: Due to skin breakdown at the eschar site.

Early antibiotic therapy reduces the risk of these outcomes by >80 %.<sup>5</sup>

When to Seek Emergency Care

Timely medical attention can be lifesaving. If you suspect Jerusalem hares’ fever, contact a healthcare provider promptly—even if symptoms seem mild.

---

**References**

1. Israeli Ministry of Health, Epidemiology of Tick‑Borne Diseases, 2022.
2. Centers for Disease Control and Prevention (CDC). “Rickettsial Diseases” 2023.
3. Cleveland Clinic. “Treatment of Spotted Fever Group Rickettsioses” 2021.
4. National Institutes of Health (NIH). “Azithromycin for Pregnant Women with Rickettsial Infections” 2020.
5. Mayo Clinic. “Rickettsial Spotted Fever – Diagnosis & Treatment” 2023.

```